GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » 12-1 Month Momentum %

Medigen Biotechnology (ROCO:3176) 12-1 Month Momentum % : -23.55% (As of Dec. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-12), Medigen Biotechnology's 12-1 Month Momentum % is -23.55%.

The industry rank for Medigen Biotechnology's 12-1 Month Momentum % or its related term are showing as below:

ROCO:3176's 12-1 Month Momentum % is ranked worse than
60.93% of 1441 companies
in the Biotechnology industry
Industry Median: -13.28 vs ROCO:3176: -23.55

Competitive Comparison of Medigen Biotechnology's 12-1 Month Momentum %

For the Biotechnology subindustry, Medigen Biotechnology's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigen Biotechnology's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Biotechnology's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Medigen Biotechnology's 12-1 Month Momentum % falls into.



Medigen Biotechnology  (ROCO:3176) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medigen Biotechnology  (ROCO:3176) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Medigen Biotechnology 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Medigen Biotechnology's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigen Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560
Medigen Biotechnology Corp is a biopharmaceutical company engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The company has four segments: Nucleic acid department: segment, which derives maximum revenue, is responsible for services of testing reagents, instruments and inspection on behalf of others; New drug and vaccine research and development segment: responsible for the development and relevant services of new drugs and vaccine; Cytotherapy department: responsible for research and development and relevant services of cytotherapy; and Generic drug, aesthetic medicine product and dietary supplement segment is responsible for production and sales and relevant services of western medicine, aesthetic medicine product and dietary supplement.

Medigen Biotechnology Headlines

No Headlines